A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
Clinical trial NCT03292185 · COMPLETED
Trial details
- NCT number
- NCT03292185
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2018-01-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.